SCHEMBL25974054

SCHEMBL25974054

N#Cc1cc(-c2cccnc2Nc2ccc(C(F)(F)F)cc2)ccc1O

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 8/20 0.44
▸ EPHX2 P34913 6/20 0.41
▸ AR P10275 2/20 0.41
▸ PGR P06401 1/20 0.41
▸ HPGD P15428 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ DHODH Q02127 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25974398 0.85 HPGD (0.40) ARPGRHPGDCYP1A2CYP3A4
SCHEMBL25974139 0.84 TRPV1 (0.43) TRPV1EPHX2DHODH
SCHEMBL25974136 0.84 EPHX2 (0.48) TRPV1EPHX2
SCHEMBL25974137 0.84 TRPV1 (0.49) TRPV1EPHX2
SCHEMBL25973897 0.79 PGR (0.42) ARPGR
SCHEMBL20552307 0.78 HPGD (0.62) TRPV1EPHX2HPGDCYP1A2CYP3A4
SCHEMBL29420826 0.78 HPGD (0.62) TRPV1EPHX2HPGDCYP1A2CYP3A4
SCHEMBL25339100 0.77 LMNA (0.43) TRPV1EPHX2ARPOLBLMNA
SCHEMBL25974055 0.77 EPHX2 (0.46) TRPV1EPHX2CYP1A2CYP3A4CYP2C9
SCHEMBL30482552 0.75 EGFR (0.47) TRPV1EPHX2ARLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146513-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback